ARCC: Lowered Ratings May Still Support Attractive Dividend Yield Potential

The analyst price target for Ares Capital has been revised lower from about $22.64 to roughly $20.77, reflecting analysts' more cautious assumptions on valuation, earnings visibility and future P/E multiples following a series of recent target cuts across the stock.

Analyst Commentary

Recent Street commentary on Ares Capital points to a more cautious stance, with price targets reduced and ratings trimmed as analysts reassess how current valuations compare with potential risks to earnings, dividend coverage and credit quality.

Bullish Takeaways

Bullish analysts who maintain neutral or constructive views see Ares Capital as having already reflected some risk in the revised price targets, which now cluster closer to the US$19 to US$20 range.
The stock's established dividend profile remains part of the investment case for some, provided net operating income holds up well enough to support ongoing distributions.
For investors focused on income, the combination of a large, diversified lending platform and a liquid, widely followed stock can be viewed as a relative strength compared with smaller business development companies.

Bearish Takeaways

Bearish analysts see “richer valuations” as limiting upside, especially with Ares Capital now carrying a rating reset to Equal Weight from Overweight alongside the latest target of US$19.
There is concern that continued non accruals and restructurings could weigh on net operating income, which in turn may pressure dividend coverage and investor confidence around payout stability.
Some bearish analysts argue that execution risk has risen, as it may be harder for Ares Capital to offset potential credit issues while keeping returns and P/E multiples aligned with prior expectations.
Lowered targets in quick succession across several research houses highlight caution that the previous valuation framework may have been too optimistic given current credit and earnings visibility risks.

What’s in the News for Ares Capital

Ares Capital has scheduled a Special or Extraordinary Shareholders Meeting for August 13, 2026, according to company event disclosures.
The company reported that from January 1, 2026 to March 31, 2026, it repurchased 0 shares for US$0 million, based on its buyback program update.
Ares Capital stated that under the share repurchase program announced on September 28, 2015, it has completed the repurchase of 8,968,851 shares for US$107.17 million, per the latest buyback tranche update.

Valuation Changes for Ares Capital

Fair Value: Revised lower from about $22.64 to roughly $20.77, indicating a reduced valuation range in the current model.
Discount Rate: Adjusted from 9.80% to about 9.24%, reflecting a slightly lower required rate of return in the updated assumptions.
Revenue Growth: Moved from an assumed 3.42% to about 1.55%, indicating a significantly more conservative growth outlook for Ares Capital.
Net Profit Margin: Updated from roughly 44.58% to about 46.99%, pointing to a modestly higher margin assumption in the latest estimates.
Future P/E: Reduced from about 17.46x to roughly 13.51x, reflecting a lower multiple being applied to Ares Capital in the updated framework.

11 views

Catalysts

About Ares Capital

Ares Capital Corporation is a leading business development company that provides flexible direct lending solutions to middle market and upper middle market companies, often in sponsor backed and M&A driven transactions.

What are the underlying business or industry changes driving this perspective?

Rising private credit penetration relative to the broadly syndicated loan market, supported by repeated bank retrenchments during volatility, should sustain strong deal flow and pricing power for ARCC, helping to stabilize revenue and support mid to high single digit earnings growth.
Increasing frequency and scale of large sponsor led LBOs opting for direct lending solutions, exemplified by the $5.5 billion Dun & Bradstreet financing, positions ARCC to deploy larger tickets at attractive spreads, supporting higher fee income and net interest margins.
Structural growth in M&A and change of control activity, with a record $3 billion backlog and a rising share of originations from new borrowers, is likely to accelerate portfolio turnover and capital structuring fees, bolstering total investment income and return on equity.
Long term expansion of mission critical B2B software and data infrastructure, coupled with low loan to value ratios and strong EBITDA growth at ARCC’s software borrowers, should keep credit costs contained and support steady net asset value per share growth and resilient net margins.
Broader institutional acceptance of private credit as a core financing channel enhances ARCC’s funding access and rating strength, allowing continued optimization of its liability stack and nonqualifying asset bucket, which should modestly expand net interest margins and earnings per share over time.

NasdaqGS:ARCC Earnings & Revenue Growth as at Dec 2025

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Ares Capital's revenue will grow by 1.6% annually over the next 3 years.
Analysts assume that profit margins will increase from 37.3% today to 47.0% in 3 years time.
Analysts expect earnings to reach $1.5 billion (and earnings per share of $1.89) by about June 2029, up from $1.1 billion today.
In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.5x on those 2029 earnings, up from 11.2x today. This future PE is lower than the current PE for the US Capital Markets industry at 39.7x.
Analysts expect the number of shares outstanding to grow by 1.79% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 9.24%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

A more active M&A cycle, reflected in record transaction review volumes of over $875 billion and a $3 billion backlog, could sustain elevated deployment opportunities and capital structuring fees. This could drive revenue and earnings growth that supports a higher share price rather than a flat one.
Persistently strong double digit EBITDA growth at portfolio companies, with interest coverage above 2 times and loan to value ratios in the low 40 percent range, may keep credit losses and nonaccruals low. This could support return on equity and net margins that justify multiple expansion and share price appreciation.
Access to low cost, long dated funding, including $6.2 billion of liquidity, unsecured notes maturing in 2031 at a 5.1 percent coupon and reduced spreads on credit facilities, could enable ARCC to profitably grow its $28.7 billion portfolio. This may expand net interest income and earnings.
The deliberate equity co investment and preferred PIK strategy, which has produced large realized gains such as the $262 million Potomac Energy Center exit and high teens to 30 percent internal rates of return, may continue to deliver periodic upside to GAAP earnings and net asset value per share. This could support a higher valuation.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $20.77 for Ares Capital based on their expectations of its future earnings growth, profit margins and other risk factors.
However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $23.0, and the most bearish reporting a price target of just $19.0.
In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $3.2 billion, earnings will come to $1.5 billion, and it would be trading on a PE ratio of 13.5x, assuming you use a discount rate of 9.2%.
Given the current share price of $17.99, the analyst price target of $20.77 is 13.4% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ares Capital?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Private Credit Expansion And M&A Activity Are Expected To Support Steady Long Term Returns